Year |
Citation |
Score |
2016 |
Radzio J, Henning T, Jenkins L, Ellis S, Farshy C, Phillips C, Holder A, Kuklenyik S, Dinh C, Hanson D, McNicholl J, Heneine W, Papp J, Kersh EN, García-Lerma JG. Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis. The Journal of Infectious Diseases. 213: 1541-5. PMID 26743846 DOI: 10.1093/Infdis/Jiw002 |
0.364 |
|
2015 |
Vishwanathan SA, Burgener A, Bosinger SE, Tharp GK, Guenthner PC, Patel NB, Birse K, Hanson DL, Westmacott GR, Henning T, Radzio J, Garcia-Lerma JG, Ball TB, McNicholl JM, Kersh EN. Cataloguing of Potential HIV Susceptibility Factors during the Menstrual Cycle of Pigtail Macaques Using a Systems Biology Approach. Journal of Virology. PMID 26109722 DOI: 10.1128/Jvi.00263-15 |
0.47 |
|
2015 |
Tsegaye TS, Butler K, Luo W, Radzio J, Srinivasan P, Sharma S, Aubert RD, Hanson DL, Dobard C, Garcia-Lerma JG, Heneine W, McNicholl JM, Kersh EN. Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 385-94. PMID 25886925 DOI: 10.1097/Qai.0000000000000642 |
0.397 |
|
2015 |
Radzio J, Spreen W, Yueh YL, Mitchell J, Jenkins L, García-Lerma JG, Heneine W. The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge. Science Translational Medicine. 7: 270ra5. PMID 25589631 DOI: 10.1126/Scitranslmed.3010297 |
0.429 |
|
2014 |
Henning TR, Hanson D, Vishwanathan SA, Butler K, Dobard C, Garcia-Lerma G, Radzio J, Smith J, McNicholl JM, Kersh EN. Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures. Aids Research and Human Retroviruses. 30: 1125-9. PMID 25313448 DOI: 10.1089/Aid.2014.0238 |
0.32 |
|
2014 |
Radzio J, Hanley K, Mitchell J, Ellis S, Deyounks F, Jenkins L, Heneine W, García-Lerma JG. Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 365-9. PMID 25202923 DOI: 10.1097/Qai.0000000000000340 |
0.493 |
|
2014 |
Kersh EN, Henning T, Vishwanathan SA, Morris M, Butler K, Adams DR, Guenthner P, Srinivasan P, Smith J, Radzio J, Garcia-Lerma JG, Dobard C, Heneine W, McNicholl J. SHIV susceptibility changes during the menstrual cycle of pigtail macaques. Journal of Medical Primatology. 43: 310-6. PMID 24779484 DOI: 10.1111/Jmp.12124 |
0.464 |
|
2014 |
Radzio J, Hanley K, Mitchell J, Ellis S, Deyounks F, Jenkins LT, Hanson D, Heneine W, García-Lerma JG. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques. Aids (London, England). 28: 1431-9. PMID 24759208 DOI: 10.1097/Qad.0000000000000294 |
0.459 |
|
2012 |
Radzio J, Aung W, Holder A, Martin A, Sweeney E, Mitchell J, Bachman S, Pau CP, Heneine W, García-Lerma JG. Prevention of Vaginal SHIV Transmission in Macaques by a Coitally-Dependent Truvada Regimen Plos One. 7. PMID 23226529 DOI: 10.1371/Journal.Pone.0050632 |
0.403 |
|
2012 |
Yap SH, Herman BD, Radzio J, Sluis-Cremer N, Tachedjian G. N348I in HIV-1 reverse transcriptase counteracts the synergy between zidovudine and nevirapine. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 153-7. PMID 22743599 DOI: 10.1097/Qai.0B013E3182657990 |
0.699 |
|
2011 |
Radzio J, Sluis-Cremer N. Subunit-specific mutational analysis of residue N348 in HIV-1 reverse transcriptase. Retrovirology. 8: 69. PMID 21859446 DOI: 10.1186/1742-4690-8-69 |
0.703 |
|
2010 |
Radzio J, Yap SH, Tachedjian G, Sluis-Cremer N. N348I in reverse transcriptase provides a genetic pathway for HIV-1 to select thymidine analogue mutations and mutations antagonistic to thymidine analogue mutations. Aids (London, England). 24: 659-67. PMID 20160634 DOI: 10.1097/Qad.0B013E328336781D |
0.663 |
|
2010 |
Sluis-Cremer N, Moore K, Radzio J, Sonza S, Tachedjian G. N348I in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations. Aids (London, England). 24: 317-9. PMID 20010074 DOI: 10.1097/Qad.0B013E3283315697 |
0.694 |
|
2008 |
Radzio J, Sluis-Cremer N. Efavirenz accelerates HIV-1 reverse transcriptase ribonuclease H cleavage, leading to diminished zidovudine excision. Molecular Pharmacology. 73: 601-6. PMID 18024510 DOI: 10.1124/Mol.107.038596 |
0.641 |
|
2008 |
Zelina S, Sheen CW, Radzio J, Mellors JW, Sluis-Cremer N. Mechanisms by which the G333D mutation in human immunodeficiency virus type 1 Reverse transcriptase facilitates dual resistance to zidovudine and lamivudine. Antimicrobial Agents and Chemotherapy. 52: 157-63. PMID 17967907 DOI: 10.1128/Aac.00904-07 |
0.686 |
|
2007 |
Xia Q, Radzio J, Anderson KS, Sluis-Cremer N. Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses. Protein Science : a Publication of the Protein Society. 16: 1728-37. PMID 17656585 DOI: 10.1110/Ps.072829007 |
0.669 |
|
2007 |
Nissley DV, Radzio J, Ambrose Z, Sheen CW, Hamamouch N, Moore KL, Tachedjian G, Sluis-Cremer N. Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT. The Biochemical Journal. 404: 151-7. PMID 17286555 DOI: 10.1042/Bj20061814 |
0.716 |
|
2005 |
Radzio J, Sluis-Cremer N. Stereo-selectivity of HIV-1 reverse transcriptase toward isomers of thymidine-5'-O-1-thiotriphosphate. Protein Science : a Publication of the Protein Society. 14: 1929-33. PMID 15937285 DOI: 10.1110/Ps.051445605 |
0.663 |
|
2005 |
Tachedjian G, Radzio J, Sluis-Cremer N. Relationship between enzyme activity and dimeric structure of recombinant HTV-1 reverse transcriptase Proteins: Structure, Function and Genetics. 60: 5-13. PMID 15852304 DOI: 10.1002/Prot.20480 |
0.68 |
|
Show low-probability matches. |